Illumina ILMN
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Illumina (ILMN) Core Market Data and Business Metrics
Latest Closing Price
$78.39Price-Earnings Ratio
-10.19Total Outstanding Shares
158.40 Million SharesDividend
No dividendSIC Description
Laboratory Analytical InstrumentsPrimary Exchange
NASDAQHeadquarters
5200 Illumina Way, San Diego, CA, 92122
Historical Stock Splits
If you bought 1 share of ILMN before September 23, 2008, you'd have 2 shares today.
| Execution Date | Split Amount |
|---|---|
| September 23, 2008 | 2-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 2,630,203 Shares | 2.22 | 3/14/2025 | 5,841,687 Shares |
| 3,286,985 Shares | 1.98 | 2/28/2025 | 6,507,335 Shares |
| 3,786,620 Shares | 1.7 | 2/14/2025 | 6,437,717 Shares |
| 1,558,738 Shares | 4.17 | 1/31/2025 | 6,506,460 Shares |
| 1,747,566 Shares | 3.42 | 1/15/2025 | 5,969,990 Shares |
| 2,512,765 Shares | 2.01 | 12/31/2024 | 5,043,808 Shares |
Cash Flow Statement
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities, Continuing | $-178 Million |
| Net Cash Flow | $79 Million |
| Exchange Gains/Losses | $-10 Million |
| Net Cash Flow From Financing Activities | $-570 Million |
| Net Cash Flow From Operating Activities, Continuing | $837 Million |
| Net Cash Flow, Continuing | $89 Million |
Income Statement
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Research and Development | $1.17 Billion |
| Gross Profit | $2.86 Billion |
| Net Income/Loss Available To Common Stockholders, Basic | $-1.22 Billion |
| Cost Of Revenue | $1.51 Billion |
| Selling, General, and Administrative Expenses | $1.09 Billion |
| Diluted Earnings Per Share | $-7.69 |
Comprehensive Income
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $-1.20 Billion |
| Other Comprehensive Income/Loss | $-1.20 Billion |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss Attributable To Parent | $-1.20 Billion |
Balance Sheet
January 1, 2024 to December 29, 2024
| Metric | Value |
|---|---|
| Noncurrent Assets | $3.56 Billion |
| Current Assets | $2.75 Billion |
| Equity Attributable To Noncontrolling Interest | $0 |
| Other Current Assets | $2.20 Billion |
| Equity Attributable To Parent | $2.37 Billion |
| Fixed Assets | $815 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||